✦ LIBER ✦

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants a randomized clinical trial

✍ Scribed by Spijkerman, Judith (author);Veenhoven, Reinier H. (author);Wijmenga-Monsuur, Alienke J. (author);Elberse, Karin E.M. (author);Van Gageldonk, Pieter G.M. (author);Knol, Mirjam J. (author);De Melker, Hester E. (author);Sanders, Elisabeth A.M. (author);Schouls, Leo M. (author);Berbers, Guy A.M. (author)

Book ID: 120992381
Publisher: American Medical Association
Year: 2013
Tongue: English
Weight: 419 KB
Volume: 310
Category: Article
ISSN: 0098-7484
DOI: 10.1001/jama.2013.228052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity of 13-valent pneumococcal

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants a randomized clinical trial

✍ Spijkerman, Judith (author);Veenhoven, Reinier H. (author);Wijmenga-Monsuur, Ali 📂 Article 📅 2013 🏛 American Medical Association 🌐 English ⚖ 419 KB

A phase 3, randomized, double-blind tria

A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil

✍ Lily Yin Weckx; Allison Thompson; Eitan Naaman Berezin; Sonia Maria de Faria; Cl 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 274 KB

A randomized, double-blind trial to eval

A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years

✍ T.F. Schwarz; J. Flamaing; H.C. Rümke; J. Penzes; C. Juergens; A. Wenz; D. Jayaw 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Assessment of functional antibacterial o

Assessment of functional antibacterial opsonophagocytic antibodies elicited by 13-valent pneumococcal conjugate vaccine administered concomitantly with trivalent influenza vaccine in a randomized clinical trial in adults aged ≥65 years

✍ Tino F. Schwarz; Beate Schmoele-Thoma 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Immunogenicity and safety study of a new

Immunogenicity and safety study of a new DTaP–IPV–Hep B–PRP-T combined vaccine compared to a licensed DTaP–IPV–Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants

✍ Pope Kosalaraksa; Usa Thisyakorn; Suwat Benjaponpitak; Kulkanya Chokephaibulkit; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 290 KB